About us

About us

Our Philosophy

We have connected our know-how to conceive new formulations with empowered properties to address efficient and convenient products for dry eye disease patients. Thanks to our strong investment in research and innovation, we intend to bring patients’ ocular comfort to the next level.

About Noxelis

Noxelis is a French ophthalmic medical device company dedicated in developing next-generation treatments, including polymers and hyaluronic acid as a cornerstone. Through its technological platform, Noxelis proposes different formulations aimed at improving medical practice and provides ophthalmologists with first-in-class therapies to treat ocular surface diseases. Noxelis was founded by a passionate and determined team to bring innovative technologies to market with one focus: improving the comfort of dry-eye disease patients.

Our Expertise

Our team is backed by 40 years of combined experience in the development and commercializsation of leading products in the hyaluronic acid industry. This unique know-how has been acquired through work in various therapeutic areas, such as aesthetic dermatology, orthopaedics viscosupplementation, and ophthalmology viscoelastic devices.
The Noxelis R&D team possesses a specific expertise in the transformation of complex polymers. The team works with new technologies to respond to the needs of dry eye patients with dedicated treatments. We translated the science acquired through the development of more than 30 class II and class III medical devices to improve topical ophthalmic product outcomes.

Our Expertise

Our team is backed by 40 years of combined experience in the development and commercializsation of leading products in the hyaluronic acid industry. This unique know-how has been acquired through work in various therapeutic areas, such as aesthetic dermatology, orthopaedics viscosupplementation, and ophthalmology viscoelastic devices.
The Noxelis R&D team possesses a specific expertise in the transformation of complex polymers. The team works with new technologies to respond to the needs of dry eye patients with dedicated treatments. We translated the science acquired through the development of more than 30 class II and class III medical devices to improve topical ophthalmic product outcomes.
0
Therapeutical Focus
0
Passionates Leaders
0
Class II & III products developed
0
years of experience in HA

Our Management Team

1

Thomas
FEVRE

Chief Executive Officer
  • 15+ years in the medical industry, including 12 in hyaluronic acid
  • Expert in Business Development & Licensing
    Coordinated 6 M&A operations
  • Created 6 companies (CH, IT, FR, PL)
  • Several CEO experiences
2

Alexandre
ADAMCZEWSKI

Chief Technology Officer
  • 20+ years in the medical industry, including 12 in hyaluronic acid
  • Polymer engineer R&D & Industrial expert
  • Participated in the development & industrialization of 30+ DM (Cl. II & III)
  • Participated in an FDA development
  • Several R&D and IP management experiences
3

Gautier
LALEVEE

Chief Scientific Officer
  • 10+ years in the medical industry & hyaluronic acid
  • Doctor of Biomaterials R&D & Industrial expert
  • Participated in the development & industrialization of 20+ DM (Cl. III)
  • Several experiences of project manager and technology transfer
4

Sarah
BELKHEIRI

Chief Marketing Officer
  • 9+ years in the medical industry & hyaluronic acid
  • Expert in Strategic & Operational Marketing
  • Product manager for 10+ HA-based MDs in ophthalmology and orthopaedics
  • Ophthalmology export manager (cataracts, glaucoma)
  • Good network of ophthalmic practitioners (KOLs)

Our Management Team

1

Thomas
FEVRE

Chief Executive Officer
  • 15+ years in the medical industry, including 12 in hyaluronic acid
  • Expert in Business Development & Licensing
    Coordinated 6 M&A operations
  • Created 6 companies (CH, IT, FR, PL)
  • Several CEO experiences
2

Alexandre
ADAMCZEWSKI

Chief Technology Officer
  • 20+ years in the medical industry, including 12 in hyaluronic acid
  • Polymer engineer R&D & Industrial expert
  • Participated in the development & industrialization of 30+ DM (Cl. II & III)
  • Participated in an FDA development
  • Several R&D and IP management experiences
3

Gautier
LALEVEE

Chief Scientific Officer
  • 10+ years in the medical industry & hyaluronic acid
  • Doctor of Biomaterials R&D & Industrial expert
  • Participated in the development & industrialization of 20+ DM (Cl. III)
  • Several experiences of project manager and technology transfer
4

Sarah
BELKHEIRI

Chief Marketing Officer
  • 9+ years in the medical industry & hyaluronic acid
  • Expert in Strategic & Operational Marketing
  • Product manager for 10+ HA-based MDs in ophthalmology and orthopaedics
  • Ophthalmology export manager (cataracts, glaucoma)
  • Good network of ophthalmic practitioners (KOLs)